Malignant Ovarian Serous Tumor — Trials

Malignant Ovarian Serous Tumor — Trials · CancerIndex

Clinical trials

Registered studies

154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 69
Recruiting: 29
Ph III recruiting: 4
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06055348	SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer	unknown	Phase 1 / Phase 2	112	Biocity Biopharmaceutics Co., Ltd.INDUSTRY	0	Sep 26, 2023	clinicaltrials

Data updated 23 days agoSource updated Sep 26, 2023source: clinicaltrials